AstraZeneca PLC (STO:AZN)
1,554.00
-5.50 (-0.35%)
Oct 31, 2025, 12:59 PM CET
AstraZeneca Employees
AstraZeneca had 94,300 employees as of December 31, 2024. The number of employees increased by 4,400 or 4.89% compared to the previous year.
Employees
94,300
Change (1Y)
4,400
Growth (1Y)
4.89%
Revenue / Employee
5.70M SEK
Profits / Employee
836.48K SEK
Market Cap
2.41T
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 94,300 | 4,400 | 4.89% |
| Dec 31, 2023 | 89,900 | 6,400 | 7.66% |
| Dec 31, 2022 | 83,500 | 400 | 0.48% |
| Dec 31, 2021 | 83,100 | 7,000 | 9.20% |
| Dec 31, 2020 | 76,100 | 5,500 | 7.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Medicover AB | 47,256 |
| Getinge AB | 11,791 |
| Nolato AB | 5,837 |
| Elekta AB | 4,556 |
| Asker Healthcare Group AB | 4,030 |
| AddLife AB | 2,181 |
| Swedish Orphan Biovitrum AB | 1,806 |
| Sectra AB | 1,296 |
AstraZeneca News
- 1 day ago - Megacap earnings to dominate next week as government shutdown continues. 11/3/25 - CME Group
- 2 days ago - AstraZeneca (AZN) Begins Phase 3 Trial for Enhertu in Lung Cancer Treatment - GuruFocus
- 2 days ago - FTSE Index shares to watch next week: BT, BP, IAG, AstraZeneca, Marks & Spencer - Invezz
- 2 days ago - Inside Celosphere 2025: Why there’s no ‘enterprise AI’ without process intelligence - VentureBeat
- 3 days ago - AstraZeneca (AZN) Reports Positive Phase 3 Trial Results for Gefurulimab - GuruFocus
- 3 days ago - FDA Streamlines Biosimilar Development; Impacts AstraZeneca (AZN) - GuruFocus
- 3 days ago - AstraZeneca Shares Surge 3% on Blockbuster Oncology Data and $2 Billion Buyback Boost - ABC Money
- 4 days ago - Astrazeneca (AZN) Stock Declines While Market Improves: Some Information for Investors - Nasdaq